Target
Erlotinib
3 abstracts
Abstract
A phase III randomized, open-label study to establish the superiority of triple oral metronomic therapy (OMCT) used in addition to chemotherapy regimen (paclitaxel + carboplatin) over chemotherapy alone for the treatment of advanced unresectable head and neck cancer squamous cell cancer (HNSCC).Org: Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Varanasi, India, Varanasi, Uttar Pradesh, India, Mumbai, India,
Abstract
Evaluating generalizability of landmark randomized controlled trials in common metastatic cancers using machine learning-based emulated trials.Org: Navajo Indian Health Service,
Abstract
A comparative study evaluating the quality of life in patients receiving chemotherapy versus oral TKI in the third line and beyond setting for advanced non–small-cell lung cancer.Org: Tata Memorial Centre, Tata Memorial Hospital (HBNI),